Cooper Companies, Inc. XNAS: COO

Cooper Companies, Inc. Live Share Price Today, Share Analysis and Chart

81.71 1.32 (1.64%)

27.29% Fall from 52W High

3.7M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Cooper Companies, Inc. is on 02 Apr 2025 for the purpose of The Cooper Companies Inc Annual General Meeting for 2025 See details

Cooper Companies, Inc. Key Metrics

Default
All financials are in USD Million and price data in USD
VIEW MORE
High Financial Strength
72.2 / 100
Mid Valuation
42.2 / 100
Technically Bearish
30.1 / 100
Falling Comet These stocks are the ones with good quality and mid-range financial aspects. However, their weak technical aspect reduces the investor's interest. View Similar Embed DVM

Cooper Companies, Inc. Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Oct '23Oct '24Oct '25Oct '26350040004500Actual RevenueAvg. Estimate
Inline

Cooper Companies, Inc.'s Revenue was higher than average estimate 1 time in past 2 years

EPS forecast

Current EPS
2
Avg. Estimate
2.9
Low Estimate
2.4
High Estimate
3.2
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 46.4% in FY25

Consensus Recommendation

19 ANALYST Recommendations
BUY

Created with Highcharts 7.2.26Hold4Buy9Strong Buy

The consensus recommendation from 19 analysts for Cooper Companies, Inc. is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Cooper Companies, Inc. Stock Analysis

Cooper Companies, Inc. stock analysis with key metrics, changes, and trends.

Cooper Companies, Inc. MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$3,895.4 M8.41%positive

Annual Revenue rose 8.41%, in the last year to $3,895.4 M. Its sector's average revenue growth for the last fiscal year was 8.73%.

Annual Net Profit$392.3 M33.34%positive

Annual Net Profit rose 33.34% in the last year to $392.3 M. Its sector's average net profit growth for the last fiscal year was 3.53%.

Price to Earning Ratio39.33-negative

Price to Earning Ratio is 39.33, higher than its sector PE ratio of 31.17.

Stock Price$81.71-18.63%negative

Stock Price fell 18.63% and underperformed its sector by 25.06% in the past year.

Quarterly Revenue$964.7 M3.55%positive

Quarterly Revenue rose 3.55% YoY to $964.7 M. Its sector's average revenue growth YoY for the quarter was 8.57%.

Quarterly Net profit$104.3 M28.45%positive

Quarterly Net profit rose 28.45% YoY to $104.3 M. Its sector's average net profit growth YoY for the quarter was 27.52%.

Debt to Equity Ratio0.32-positive

Debt to Equity Ratio of 0.32 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)5.02 %5.02%negative

Return on Equity(ROE) for the last financial year was 5.02%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding82.36 %1.21%positive

Mutual Fund Holding increased by 1.21% in the last quarter to 82.36.

Promoter Share Holding1.43 %0.24%positive

Promoter Share Holding increased by 0.24% in the most recent quarter to 1.43%.

Interest Coverage Ratio6.09-positive

Interest Coverage Ratio is 6.09, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding99.13 %-0.14%negative

Institutional Holding decreased by 0.14% in the last quarter to 99.13.

VIEW LESS


Loading data..

Cooper Companies, Inc. - Company Profile

What does Cooper Companies, Inc. do?

CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.

Cooper Companies, Inc. Management structure

All Gross Remunerations are in USD
Mr. Albert G. White, III
Director, President and Chief Executive Officer
15.43 M
2024
Gross Remuneration
Year
Mr. Daniel G. McBride, Esq.
Executive Vice President and Chief Operating Officer
4.76 M
2024
Gross Remuneration
Year
Mr. Brian G. Andrews
Executive Vice President, Chief Financial Officer and Treasurer
3.73 M
2024
Gross Remuneration
Year
Ms. Holly R. Sheffield
President, CooperSurgical, Inc.
3.45 M
2024
Gross Remuneration
Year
Mr. Gerard H. Warner, III
President, CooperVision, Inc.
3.13 M
2024
Gross Remuneration
Year
Mr. Nicholas S. Khadder
Vice President, General Counsel and Secretary
-
2024
Gross Remuneration
Year

Cooper Companies, Inc. Board of directors

All Gross Remunerations are in USD
Mr. William A. Kozy
Vice Chairman of the Board and Lead Independent Di
-
2025
Gross Remuneration
Year

Cooper Companies, Inc. FAQ

How is Cooper Companies, Inc. today?
Cooper Companies, Inc. today is trading in the green, and is up by 1.64% at 81.71.
Cooper Companies, Inc. is currently trading up 1.64% on an intraday basis. In the past week the stock rose 0.60%. stock has been down -12.75% in the past quarter and fell -18.63% in the past year. You can view this in the overview section.